JDRF randomized clinical trial to assess the efficacy of real-time continuous glucose monitoring in the management of type 1 diabetes: Research design and methods

Diabetes Technology and Therapeutics

Volumn 10, Issue 4, 2008, Pages 310-321

  Tamborlane, William V ^a   Ruedy, Katrina J ^b   Wysocki, Timothy ^b   O'Grady, Michael ^b   Kollman, Craig ^b   Block, Jennifer ^b   Chase, H Peter ^b   Hirsch, Irl ^b   Huang, Elbert ^b   Beck, Roy W ^b   Wilson, Darrell ^b   Lawrence, Jean ^b   Laffel, Lori ^b  

^a JAEB CENTER FOR HEALTH RESEARCH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C;

ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; CROSSOVER PROCEDURE; DIABETIC PATIENT; GLYCEMIC CONTROL; HEALTH CARE COST; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTERMETHOD COMPARISON; JUVENILE DIABETES MELLITUS; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PARALLEL DESIGN; PILOT STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SENSOR; STANDARD; TREATMENT OUTCOME;

ADOLESCENT; ADULT; BLOOD GLUCOSE SELF-MONITORING; CHILD; COHORT STUDIES; COST-BENEFIT ANALYSIS; DIABETES MELLITUS, TYPE 1; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; PATIENT SATISFACTION; PILOT PROJECTS; QUESTIONNAIRES; SAMPLE SIZE; TREATMENT OUTCOME;

EID: 50049107110     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2007.0302     Document Type: Article

References (31)

1. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986.
2. The Diabetes Control and Complications Trial Research Group: Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. J Pediatr 1994;125:177-188.
3. The Diabetes Control and Complications Trial Research Group: Adverse events and their association with treatment regimens in the diabetes control and complications trial. Diabetes Care 1995;18:1415-1427.
4. Bergada I, Suissa S, Dufresne J, Schiffrin A: Severe hypoglycemia in IDDM children. Diabetes Care 1989;12:239-244.
5. Boland E, Monsod T, Delucia M, Brandt CA, Fernando S, Tamborlane WV: Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes. Diabetes Care 2001;24:1858-1862.
6. Davis E, Keating B, Byrne G, Russell M, Jones T: Hypoglycemia: incidence and clinical predictors in a large population-based sample of children and adolescents with IDDM. Diabetes Care 1997;20:22-25.
7. The DCCT Research Group: Epidemiology of severe hypoglycemia in the diabetes control and complications trial. Am J Med 1991;90:450-459.
8. Kovatchev BP: Is glycemic variability important to assessing antidiabetes therapies? Curr Diabetes Rep 2006;6:350-356.
9. Diabetes Research in Children Network (DirecNet) Study Group: A randomized multicenter trial comparing the GlucoWatch Biographer with standard glucose monitoring in children with type 1 diabetes. Diabetes Care 2005;28:1101-1106.
10. Bulsara MK, Davis EA, Holman CDJ, Jones TW: The impact of a decade of changing treatment on rates of severe hypoglycemia in a population-based cohort of children with type 1 diabetes. Diabetes Care 2004;27:2293-2298.
11. Craig ME, Handelsman P, Donaghue KC, Chan A, Blades B, Laina R, Bradford D, Middlehurst A, Ambler G, Verge CF, Crock P, Moore P, Silink M; NSW/ACT HbA1c Study Group: Predictors of glycaemic control and hypoglycaemia in children and adolescents with type 1 diabetes from NSW and the ACT. Med J Aust 2002;177:235-238.
12. Davis EA, Keating B, Byrne GC, Russell M, Jones TW: Impact of improved glycaemic control on rates of hypoglycaemia in insulin dependent diabetes mellitus. Arch Dis Child 1998;78:111-115.
13. Rewers A, Chase HP, Mackenzie T, Walravens P, Roback M, Rewers M, Hamman RF, Klingensmith G: Predictors of acute complications in children with type 1 diabetes. JAMA 2002;287:2511-2518.
14. Rosilio M, Cotton JB, Wieliczko MC, Gendrault B, Carel JC, Couvaras O, Ser N, Bougnères PF, Gillet P, Soskin S, Garandeau P, Stuckens C, Le luyer B, Jos J, Bony-Trifunovic H, Bertrand AM, Leturcq F, Lafuma A: Factors associated with glycemic control: a cross-sectional nationwide study in 2,579 French children with type 1 diabetes. Diabetes Care 1998;21:1146-1153.
15. Wagner VM, Grabert M, Holl RW: Severe hypoglycaemia, metabolic control and diabetes management in children with type 1 diabetes in the decade after the Diabetes Control and Complications Trial - a large-scale multicentre study. Eur J Pediatr 2005;164:73-79.
16. Weinzimer SA, Ahern JH, Doyle EA, Vincent MR, Dziura J, Steffen AT, Tamborlane WV: Persistence of benefits of continuous subcutaneous insulin infusion in very young children with type 1 diabetes: a follow-up report. Pediatrics 2004;114:1601-1605.
17. The Diabetes Control and Complications Trial Research Group: Hypoglycemia in the Diabetes Control and Complications Trial. Diabetes 1997;46:271-286.
18. Diabetes Research in Children Network (DirecNet) Study Group: Comparison of fingerstick hemoglobin A1c levels assayed by DCA 2000 with the DCCT/EDIC central laboratory assay: results of a Diabetes Research in Children Network (DirecNet) Study. Pediatr Diabetes 2005;6:13-16.
19. Service FJ, Molnar GD, Rosevear JW, Ackerman E, Gatewood LC, Taylor WF: Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes 1970;19:644-655.
20. Varni JW, Burwinkle TM, Jacobs JR, Gottschalk M, Kaufman F, Jones KL: The PedsQL™ in Type 1 and Type 2 diabetes: reliability and validity of the Pediatric Quality of Life Inventory™ Generic Core Scales and Type 1 Diabetes Module. Diabetes Care 2003;26:631-637.
21. Green LB, Wysocki T, Reineck BM: Fear of hypoglycemia in children and adolescents with diabetes. J Pediatr Psychol 1990;15:633-641.
22. Polonsky WH, Anderson BJ, Lohrer PA, Welch G, Jacobson AM, Aponte JE, Schwartz CE: Assessment of diabetes-related distress. Diabetes Care 1995;18:754-760.
23. Antisdel JE: Diabetes-specific distress among parents of youth with type 1 diabetes [abstract 6123]. Dissertation Abstracts Int 2001;61:1-2.
24. Ware JE, Kosinski M, Keller SD: A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220-233.
25. Diabetes Research in Children Network (DirecNet) Study Group: Youth and parent satisfaction with clinical use of the Glucowatch G2 Biographer in the management of pediatric type 1 diabetes. Diabetes Care 2005;28:1929-1935.
26. Horsman J, Furlong W, Feeny D, Torrance G: The Health Utilities Index (HUI®): concepts, measurement properties and applications. Health Qual Life Outcomes 2003;1:54.
27. Neumann P, Goldie S, Weinstein M: Preference-based measures in economic evaluation in health care. Annu Rev Public Health 2000;21:587-611.
28. Huang E, Brown S, Ewigman B, Foley E, Meltzer D: Patient perceptions of quality of life with diabetes-related complications and treatments. Diabetes Care 2007;30:2478-2483.
29. Bala M, Mauskopf J, Wood L: Willingness to pay as a measure of health benefits. Pharmoeconomics 1999;1:9-18.
30. Diabetes Research in Children Network (DirecNet) Study Group: Use of the DirecNet Applied Treatment Algorithm (DATA) for diabetes management with a real-time continuous glucose monitor (the Freestyle Navigator). Pediatr Diabetes 2008;9:142-147.
31. The DirecNet Study Group: The accuracy of the Freestyle Navigator continuous glucose sensor in the inpatient and outpatient setting in children with type 1 diabetes. Diabetes Care 2007;30:59-64.